ArticleJournal of clinical medicine2022

Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study.

Roberta Lanzillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.